S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Fair value lists · updated after every US close (19 Oct 2026)

Undervalued & overvalued stocks

Ranked by the gap to fair value — then sort by financial health, growth, debt, profitability or dividends to separate real bargains from value traps.

Most undervalued Most overvalued Undervalued + quality
Sort by Gap to fair value ↑ X-Ray Score Financial health Growth Lowest debt Profitability (ROIC) Dividend yield Piotroski F-Score
Then by
Only show Financial health ≥ 70 Low debt (< 1.5× EBITDA) ✓ Growth ≥ 50 Pays dividend ≥ 2% ✓ Piotroski ≥ 7

Most overvalued — US stocks

Sorted by Gap to fair value (low → high) · 8 shown of 8
$465.04$372.25
-20%
55
66
78
1.1×
24%
0.9%
9/9
OvervaluedMedium uncertainty · 30% margin
$352.21$280.17
-21%
53
67
75
Net cash
47%
0.2%
7/9
OvervaluedHigh uncertainty · 40% margin
$220.03$174.02
-21%
54
74
87
1.5×
21%
0.2%
8/9
OvervaluedHigh uncertainty · 40% margin
$70.38$55.55
-21%
38
26
63
4.4×
8%
2.9%
7/9
OvervaluedHigh uncertainty · 40% margin
$966.26$761.74
-21%
48
65
58
1.6×
17%
0.8%
8/9
OvervaluedMedium uncertainty · 30% margin
$538.05$422.90
-21%
48
81
80
Net cash
10%
—
8/9
OvervaluedHigh uncertainty · 40% margin
$390.70$307.16
-21%
42
43
59
3.9×
27%
0.7%
7/9
OvervaluedMedium uncertainty · 30% margin
$204.92$156.35
-24%
32
29
61
19.8×
-3%
—
7/9
OvervaluedLow uncertainty · 20% margin
Click any column to sort · 8 stocks in this listPage 1 of 1
Financial health (0–100)
Piotroski F-Score, Altman Z, interest cover, liquidity: ranked within sector.
Growth (0–100)
Revenue, EPS and free-cash-flow growth over the last three years.
Net debt / EBITDA
Years of earnings needed to repay debt. "Net cash" means more cash than debt.
ROIC
Return on invested capital: how efficiently the business earns profit.
Dividend yield
Trailing 12-month dividends ÷ price.
Piotroski F-Score (0–9)
9 accounting tests of profitability, leverage and efficiency.

Model estimates, not price targets or recommendations. For educational purposes only. Not financial advice.